AI Article Synopsis
- Congenital hypogonadotropic hypogonadism (CHH) is a genetic condition that leads to incomplete puberty and infertility due to insufficient gonadotropin secretion, often linked to mutations in the GNRHR gene.
- A case study of a 19-year-old male showed that after treatment with testosterone, he experienced unexpected spontaneous puberty and improvements in hormone levels two years after stopping the treatment.
- Genetic testing is important to differentiate CHH from similar conditions, as patients can sometimes recover naturally without ongoing hormone therapy.
Article Abstract
Background: Congenital hypogonadotropic hypogonadism (CHH) is a clinically and genetically heterogeneous disease characterized by absent or incomplete puberty and infertility. Clinical characteristics are secondary to insufficient gonadotropin secretion, caused by deficient gonadotropin-releasing hormone (GnRH) production, secretion, or action. Loss-of-function variants of the gonadotropin-releasing hormone receptor (GNRHR) are associated with CHH without anosmia. CHH was previously considered a permanent condition, but in the past two decades, cases of spontaneous recovery of CHH have been reported. The reversal of hypogonadism in CHH is currently unpredictable, and can happen unnoticed.
Case Presentation: The male proband was diagnosed with CHH due to compound heterozygosity for two previously reported pathogenic missense variants in the GNRHR gene, NM_000406.2:c.416G > A (NP_000397.1:p.Arg139His) and c.785G > A (p.Arg262Gln) at 16 years of age. In addition to arrested partial puberty, he had a low testosterone level, gonadotropins in the range of early puberty, and a normal inhibin B level. A therapy with increasing doses of intramuscular testosterone undecanoate was received for 2.5 years, while there was no change in testicular volume. At the age of 19 years, testosterone supplementation was interrupted. During the next two years, he had spontaneous pubertal development to achieve a testicular volume of 20 mL, with normal adult levels of gonadotropins and testosterone.
Conclusions: Genetic diagnostics can help discriminate congenital hypogonadotropic hypogonadism, deserving therapeutic intervention, from the self-limited constitutional delay of growth and puberty (CDGP). Patients with GNRHR associated hypogonadism can experience spontaneous recovery of the hypothalamic-pituitary-gonadal axis. Spontaneous testis enlargement in patients with central hypogonadism not taking gonadotropins or pulsatile GnRH therapy can indicate recovery of hypogonadism.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652797 | PMC |
| http://dx.doi.org/10.1186/s13052-022-01377-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Liver assistive devices in acute liver failure: Current use and future directions.
Best Pract Res Clin Gastroenterol
December 2024
Department of Critical Care Medicine, University of Alberta, Edmonton, Canada; Division of Gastroenterology (Liver Unit), University of Alberta, Edmonton, Canada. Electronic address:
Acute liver failure (ALF) is a rare syndrome where rapid deterioration of liver function occurs after an acute insult in a patient without prior chronic liver disease and leads to jaundice, hepatic encephalopathy (HE), and oftentimes multiorgan failure (MOF). At this time, the only definitive treatment for ALF is LT but some patients, particularly APAP-induced ALF patients, may have ongoing regenerative capacity of the liver and may not require LT with ongoing supportive management. As a result, extracorporeal liver support (ECLS) has been a topic of interest both as a bridge to LT and as a bridge to spontaneous recovery and aims to remove damaging toxins that further aggravate liver failure, stimulate regeneration of the liver, and improve pathophysiologic consequences of liver failure.
View Article and Find Full Text PDFSafety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial.
Lancet Neurol
January 2025
Spinal Cord Injury Center, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
Background: Spinal cord injury results in permanent neurological impairment and disability due to the absence of spontaneous regeneration. NG101, a recombinant human antibody, neutralises the neurite growth-inhibiting protein Nogo-A, promoting neural repair and motor recovery in animal models of spinal cord injury. We aimed to evaluate the efficacy of intrathecal NG101 on recovery in patients with acute cervical traumatic spinal cord injury.
View Article and Find Full Text PDFLessons of the month: Cerebrospinal Fluid Leak-associated Ventriculitis - a case report.
Clin Med (Lond)
December 2024
Internal Medicine trainee, St Mary's Hospital, Praed street, London, W2 1NY, UK. Electronic address:
We present a case of a 74-year-old woman with headaches, pyrexia, and intermittent right-sided otorrhoea and rhinorrhoea. Her nasal discharge tested positive for Beta-2-Transferrin, confirming a cerebrospinal fluid (CSF) leak. High-resolution CT (HRCT) mastoids showed a defect in the right tegmen, and CSF within the middle ear and mastoid air cells.
View Article and Find Full Text PDFThe Clinical Status of Patients With Lumbar Spinal Stenosis Reflects Their Individual Decision to Undergo or Defer Lumbar Spinal Surgery.
J Am Acad Orthop Surg
December 2024
From the Spinal Research Laboratory, Department of Physical Therapy, The Stanley Steyer School of Health Professions, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel (Soroka, Weisman, and Masharawi), the Department of Physical Therapy, Steinhardt School of Culture Education and Human Development, New York University, New York, NY (Lubetzky and Moffat), the Department of Mathematics and Statistics, Dalhousie University, Halifax, Canada (Murphy), the Israel Spine Center, Assuta Hospital, Tel-Aviv, Israel (Ashkenazi and Floman), the Spine Unit, Meir Medical Center, Kfar Saba, Israel (Shabat), and the Department of Orthopedics, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel (Shabat).
Objective: To evaluate whether functional, clinical, and self-reported tests reflect lumbar spinal stenosis patients' decisions to undergo or defer surgery.
Methods: Among 108 participants, 77 chose surgery (SG), and 31 opted to wait and see (WaSG) whether they got better spontaneously. Both groups were assessed at baseline (t0) and 3 months (t1), with additional self-reported measures at 6 (t2) and 12 months (t3).
A case report of adenomyosis-induced spontaneous rupture in an unscarred and unpregnant uterus.
Medicine (Baltimore)
December 2024
Department of Ultrasound, Tongde Hospital of Zhejiang Province, Hangzhou, China.
Rationale: Spontaneous uterine rupture, although rare, is a life-threatening obstetric emergency with a high maternal and fetal mortality rate. It can occur without warning, leading to severe complications, including hemorrhage, shock, and fetal demise. The risk factors contributing to uterine rupture are diverse and include a history of uterine surgery (such as cesarean section), trauma to the uterus, abnormal uterine contractions during labor, and underlying conditions like adenomyosis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!